Adial Pharmaceuticals Inc

Research Adial Pharmaceuticals Inc (ADIL) on Bullrun: market cap USD 3.91M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerADIL
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 3.91M
• Financial periodFY2025
• Net income-USD 7.98M

Valuation Snapshot

latest market cap is USD 3.91M.

About Adial Pharmaceuticals Inc

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. The company was founded in 2010 and is based in Glen Allen, Virginia.

Frequently asked questions

What is Adial Pharmaceuticals Inc's market cap?

Adial Pharmaceuticals Inc's market capitalization is USD 3.91M.

What does Adial Pharmaceuticals Inc do?

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders.